Study of APD421 as PONV Treatment (no Prior Prophylaxis)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Double-blind, randomised, parallel-group, placebo-controlled, adaptive, seamless, dose-selecting study to compare the efficacy of APD421 to placebo as treatment of established PONV, in patients who have not had prior PONV prophylaxis.
Epistemonikos ID: 81b553e6bfae27e4c830980fc1ea415e5c296f2a
First added on: May 12, 2024